Valuation: Ipca Laboratories Limited

Market Cap 49TCr 513.21Cr 439.77Cr 412.07Cr 376.41Cr 710.36Cr 717.37Cr 4.86TCr 1.89TCr 25TCr 1.93TCr 1.89TCr 82TCr P/E 2027 *
32.2x
P/E 2028 * 27.6x
Enterprise Value 48TCr 502.04Cr 430.2Cr 403.1Cr 368.21Cr 694.9Cr 701.75Cr 4.75TCr 1.85TCr 24TCr 1.89TCr 1.84TCr 80TCr EV / Sales 2027 *
4.35x
EV / Sales 2028 * 3.83x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day+1.24%
1 week+2.56%
Current month+11.71%
1 month+9.83%
3 months+23.73%
6 months+28.21%
Current year+37.60%
1 week 1,880.4
Extreme 1880.4
1,992
1 month 1,674.4
Extreme 1674.4
1,992
Current year 1,391.8
Extreme 1391.8
1,992
1 year 1,251.6
Extreme 1251.6
1,992
3 years 856.8
Extreme 856.8
1,992
5 years 669.8
Extreme 669.8
1,992
10 years 200
Extreme 200
1,992
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap.
19/12/24 Sell 40,00,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%+2.56%+36.10%+118.47% 513.21Cr
-1.06%+0.65%+77.42%+122.82% 1,10000Cr
+0.04%+0.75%+53.10%+64.29% 66TCr
+0.48%+2.65%+28.06%+81.19% 47TCr
-0.40%+1.63%+44.06%+44.09% 37TCr
-0.30%+0.87%+26.60%+41.74% 30TCr
-1.16%+2.55%+4.09%+14.38% 26TCr
-0.36%+3.99%+53.31%+72.49% 24TCr
+0.84%+3.62%-11.58%-52.00% 21TCr
+1.38%+3.72%+30.33%+93.56% 18TCr
Average +0.25%+2.95%+34.15%+60.10% 38.08TCr
Weighted average by Cap. +0.22%+2.21%+45.92%+71.57%

Financials

2027 *2028 *
Net sales 11TCr 115.34Cr 99Cr 93Cr 85Cr 159.64Cr 161.22Cr 1.09TCr 425.24Cr 5.55TCr 433.06Cr 423.63Cr 18TCr 12TCr 128.66Cr 110.25Cr 103.31Cr 94Cr 178.09Cr 179.84Cr 1.22TCr 474.38Cr 6.19TCr 483.1Cr 472.58Cr 20TCr
Net income 1.51TCr 16Cr 14Cr 13Cr 12Cr 22Cr 22Cr 150.46Cr 59Cr 764.11Cr 60Cr 58Cr 2.53TCr 1.78TCr 19Cr 16Cr 15Cr 14Cr 26Cr 26Cr 176.8Cr 69Cr 897.9Cr 70Cr 69Cr 2.97TCr
Net Debt -1.06TCr -11Cr -9.57Cr -8.97Cr -8.19Cr -15Cr -16Cr -105.8Cr -41Cr -537.32Cr -42Cr -41Cr -1.78TCr -2TCr -21Cr -18Cr -17Cr -15Cr -29Cr -29Cr -198.26Cr -77Cr -1.01TCr -79Cr -77Cr -3.33TCr
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
26/26/26 1,952.40 +1.24% 4,55,426
25/26/25 ₹1,928.50 +0.42% 4,27,720
24/26/24 ₹1,920.40 +0.48% 2,77,434
21/26/21 ₹1,911.20 +0.58% 1,94,059
20/26/20 ₹1,900.10 -0.19% 2,36,586
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,928.50INR
Average target price
1,972.28INR
Spread / Average Target
+2.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock